Publications en collaboration avec des chercheurs de Instituto Universitario de Oncologia del Principado de Asturias (30)

2023

  1. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma

    Frontiers in Endocrinology, Vol. 13

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  3. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Antiproliferative and palliative activity of flavonoids in colorectal cancer

    Biomedicine and Pharmacotherapy, Vol. 143

  2. Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  3. Immune cell infiltrates and neutrophil-to-lymphocyte ratio in relation to response to chemotherapy and prognosis in laryngeal and hypopharyngeal squamous cell carcinomas

    Cancers, Vol. 13, Núm. 9

2020

  1. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

    Leukemia, Vol. 34, Núm. 11, pp. 3007-3018

  2. Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (Estahep clinical trial)

    Cancers, Vol. 12, Núm. 7, pp. 1-14

  3. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

    Liver International, Vol. 40, Núm. 6, pp. 1467-1476

  4. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome

    Nature Cancer, Vol. 1, Núm. 11, pp. 1066-1081

2019

  1. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

    Cell Metabolism, Vol. 30, Núm. 4, pp. 754-767.e9

  2. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074

2018

  1. De novo biosynthesis of myricetin, kaempferol and quercetin in Streptomyces albus and Streptomyces coelicolor

    PLoS ONE, Vol. 13, Núm. 11

  2. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

    Cell Death and Disease, Vol. 9, Núm. 10

  3. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

    Nature Medicine, Vol. 24, Núm. 6, pp. 868-880

  4. Top ten errors of statistical analysis in observational studies for cancer research

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 954-965

2016

  1. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47954-47965

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12